Healthcare provider profile · identity verified

Katelyn J. Ahern, APRN

Nurse Practitioner · KEENE, NH · NPI 1922438944

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	430	112
Levothyroxine Sodium	Levothyroxine Sodium	407	104
Lisinopril	Lisinopril	360	99
Pantoprazole Sodium	Pantoprazole Sodium	235	58
Amlodipine Besylate	Amlodipine Besylate	223	56
Losartan Potassium	Losartan Potassium	208	52
Omeprazole	Omeprazole	204	63
Hydrochlorothiazide	Hydrochlorothiazide	202	63
Gabapentin	Gabapentin	153	49
Eliquis	Apixaban	132	24
Metoprolol Succinate	Metoprolol Succinate	124	34
Metformin Hcl Er	Metformin Hcl	123	31
Trazodone Hcl	Trazodone Hcl	119	39
Furosemide	Furosemide	116	36
Albuterol Sulfate Hfa	Albuterol Sulfate	98	42
Famotidine	Famotidine	96	28
Metoprolol Tartrate	Metoprolol Tartrate	90	25
Metformin Hcl	Metformin Hcl	88	24
Simvastatin	Simvastatin	86	30
Allopurinol	Allopurinol	84	20
Fluoxetine Hcl	Fluoxetine Hcl	84	19
Citalopram Hbr	Citalopram Hydrobromide	82	22
Sertraline Hcl	Sertraline Hcl	81	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	13
Pravastatin Sodium	Pravastatin Sodium	73	21
Prednisone	Prednisone	73	32
Montelukast Sodium	Montelukast Sodium	71	14
Lorazepam	Lorazepam	69	27
Alendronate Sodium	Alendronate Sodium	64	14
Escitalopram Oxalate	Escitalopram Oxalate	64	16
Tamsulosin Hcl	Tamsulosin Hcl	64	22
Oxycodone Hcl	Oxycodone Hcl	61	16
Pregabalin	Pregabalin	57	13
Fluticasone Propionate	Fluticasone Propionate	56	21
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	suppressed
Atenolol	Atenolol	50	14
Rosuvastatin Calcium	Rosuvastatin Calcium	50	18
Ozempic	Semaglutide	49	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Duloxetine Hcl	Duloxetine Hcl	46	15
Synthroid	Levothyroxine Sodium	44	15
Lovastatin	Lovastatin	41	12
Clopidogrel	Clopidogrel Bisulfate	40	11
Doxycycline Hyclate	Doxycycline Hyclate	40	26
Meloxicam	Meloxicam	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	12
Trulicity	Dulaglutide	38	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	12
Alprazolam	Alprazolam	33	suppressed
Buspirone Hcl	Buspirone Hcl	33	12
Clonidine Hcl	Clonidine Hcl	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	11
Potassium Chloride	Potassium Chloride	33	12
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	11
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Nystatin	Nystatin	27	18
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Fluconazole	Fluconazole	26	20
Glimepiride	Glimepiride	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Myrbetriq	Mirabegron	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	15
Calcitriol	Calcitriol	19	suppressed
Diazepam	Diazepam	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Oxycontin	Oxycodone Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Baclofen	Baclofen	16	suppressed
Estradiol	Estradiol	16	suppressed
Topiramate	Topiramate	16	suppressed
Azithromycin	Azithromycin	15	14
Chlorthalidone	Chlorthalidone	15	suppressed
Glyburide	Glyburide	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	14	suppressed
Finasteride	Finasteride	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Ramipril	Ramipril	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Xarelto	Rivaroxaban	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error